Tricuspid regurgitation

1 paper

Humans1

Trial sponsors

Asan Medical Center
1 trialPhase 356 people
Matsumoto Takashi
1 trialPhase 1/220 people

Latest

5 in 12 months

Journal of Cardiovascular Imaging15 Sep

Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial

Randomised trial in 56 peopleEmpagliflozin

ESC Heart Failure1 Sep

Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF

Cohort study of 142 peopleDapagliflozin

Journal of Clinical Medicine27 Aug

Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review

ReviewSGLT2 inhibitors

Journal of the American College of Cardiology19 Aug

AI-ECG Detection of Structural Heart Disease in the Community Setting: Transportability and Spectrum Effects in the PREVUE-VALVE Study

Cohort study of 2,402 peopleBiomarkers

AHA Scientific Sessions 2025 Abstract3 Nov

Association of SGLT2 Inhibitor Use with Clinical Outcomes in Patients with Tricuspid Regurgitation in the Absence of Left Ventricular Systolic Dysfuncton: A Propensity Score-Matched Analysis

Study in peopleInterventions